Endocrinology, Vol 137, 3710-3716, Copyright © 1996 by Endocrine Society

ARTICLES

Proglucagon gene expression is induced by gastrin-releasing peptide in a mouse enteroendocrine cell line

F Lu, T Jin and DJ Drucker
Department of Medicine, Banting and Best Diabetes Center, Toronto Hospital, University of Toronto, Ontario, Canada.

The proglucagon gene is expressed in a cell-specific manner in the A cells of the islets and the L cells of the intestine; however, the physiological factors that regulate proglucagon gene expression are not well understood. Although insulin inhibits proglucagon gene transcription in the islets, peptides that stimulate proglucagon gene expression have not been identified. We show here that gastrin- releasing peptide (GRP) induces proglucagon messenger RNA transcripts in STC-1 enteroendocrine cells. The GRP induction of proglucagon gene expression was dose dependent, detectable by 4 h after GRP treatment, and sustained, i.e. detectable after a 24-h GRP incubation. GRP also induced the transcriptional activity of rat proglucagon promoter- luciferase plasmids in transfected STC-1 cells. The GRP induction of proglucagon promoter activity was attenuated, but not eliminated, after deletion of 5'-flanking sequences containing the proglucagon gene cAMP response element (CRE). A mutation in the CRE previously shown to abrogate cAMP responsiveness and CRE-binding protein binding was associated with a reduction in the transcriptional response to GRP. The proglucagon CRE also conferred GRP responsiveness to a truncated proglucagon promoter in STC-1 cells. These observations identify GRP as a peptide activator of proglucagon gene expression and provide evidence linking the proglucagon gene CRE to the physiological control of proglucagon gene expression.

This article has been cited by other articles:

				T. Jin Mechanisms underlying proglucagon gene expression J. Endocrinol., July 1, 2008; 198(1): 17 - 28. [Abstract] [Full Text] [PDF]

				F. Yi, J. Sun, G. E. Lim, I. G. Fantus, P. L. Brubaker, and T. Jin Cross Talk between the Insulin and Wnt Signaling Pathways: Evidence from Intestinal Endocrine L Cells Endocrinology, May 1, 2008; 149(5): 2341 - 2351. [Abstract] [Full Text] [PDF]

				S. Lotfi, Z. Li, J. Sun, Y. Zuo, P. P. L. Lam, Y. Kang, M. Rahimi, D. Islam, P. Wang, H. Y. Gaisano, et al. Role of the Exchange Protein Directly Activated by Cyclic Adenosine 5'-Monophosphate (Epac) Pathway in Regulating Proglucagon Gene Expression in Intestinal Endocrine L Cells Endocrinology, August 1, 2006; 147(8): 3727 - 3736. [Abstract] [Full Text] [PDF]

				P. Wang, T. Liu, Z. Li, X. Ma, and T. Jin Redundant and Synergistic Effect of Cdx-2 and Brn-4 on Regulating Proglucagon Gene Expression Endocrinology, April 1, 2006; 147(4): 1950 - 1958. [Abstract] [Full Text] [PDF]

				Z. Ni, Y. Anini, X. Fang, G. Mills, P. L Brubaker, and T. Jin Transcriptional Activation of the Proglucagon Gene by Lithium and beta -Catenin in Intestinal Endocrine L Cells J. Biol. Chem., January 3, 2003; 278(2): 1380 - 1387. [Abstract] [Full Text] [PDF]

				M. Nian, D. J. Drucker, and D. Irwin Divergent regulation of human and rat proglucagon gene promoters in vivo Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G829 - G837. [Abstract] [Full Text] [PDF]

				A. B. Damholt, A. M. J. Buchan, and H. Kofod Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose Endocrinology, April 1, 1998; 139(4): 2085 - 2091. [Abstract] [Full Text] [PDF]